{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T02:58:43Z","timestamp":1784084323511,"version":"3.55.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,18]],"date-time":"2021-07-18T00:00:00Z","timestamp":1626566400000},"content-version":"am","delay-in-days":320,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006537","name":"Campus France","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006537","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.psychres.2020.113293","type":"journal-article","created":{"date-parts":[[2020,7,12]],"date-time":"2020-07-12T01:39:20Z","timestamp":1594517960000},"page":"113293","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Association between schizophrenia and Toxoplasma gondii infection in Algeria"],"prefix":"10.1016","volume":"291","author":[{"given":"Amir Med","family":"Kezai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Lecoeur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustapha","family":"Bounechada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Med Lamine","family":"Alouani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Marion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2020.113293_bib0001","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.medmal.2017.09.019","article-title":"Premi\u00e8re caract\u00e9risation mol\u00e9culaire de deux souches alg\u00e9riennes de Toxoplasma gondii isol\u00e9es de deux cas de toxoplasmose cong\u00e9nitale","volume":"48","author":"Bachi","year":"2018","journal-title":"M\u00e9d. Mal. Infect"},{"key":"10.1016\/j.psychres.2020.113293_bib0002","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4103\/1673-5374.198971","article-title":"Kynurenine pathway metabolism and neuroinflammatory disease","volume":"12","author":"Braidy","year":"2017","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.psychres.2020.113293_bib0003","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3389\/fpsyt.2011.00063","article-title":"Exposure to prenatal infection and risk of schizophrenia","volume":"2","author":"Brown","year":"2011","journal-title":"Front. Psychiatry."},{"key":"10.1016\/j.psychres.2020.113293_bib0004","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.bbi.2019.01.026","article-title":"Large-scale study of Toxoplasma and Cytomegalovirus shows an association between infection and serious psychiatric disorders","volume":"79","author":"Burgdorf","year":"2019","journal-title":"Brain. Behav. Immun."},{"key":"10.1016\/j.psychres.2020.113293_bib0005","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1093\/schbul\/sbm008","article-title":"Effects of Toxoplasma gondii infection on the brain","volume":"33","author":"Carruthers","year":"2007","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2020.113293_bib0006","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3390\/pathogens9030234","article-title":"The Bradyzoite: a key developmental stage for the persistence and pathogenesis of toxoplasmosis","volume":"9","author":"Cerutti","year":"2020","journal-title":"Pathogens"},{"key":"10.1016\/j.psychres.2020.113293_bib0007","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.biopsych.2007.05.025","article-title":"Brain metabolite abnormalities in the white matter of elderly schizophrenic subjects: implication for glial dysfunction","volume":"62","author":"Chang","year":"2007","journal-title":"Biol. Psychiatry."},{"key":"10.1016\/j.psychres.2020.113293_bib0008","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1007\/s00436-017-5478-y","article-title":"Toxoplasma gondii and schizophrenia: a review of published RCTs","volume":"116","author":"Chorlton","year":"2017","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.psychres.2020.113293_bib0009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005643","article-title":"GLT-1-dependent disruption of CNS glutamate homeostasis and neuronal function by the protozoan parasite Toxoplasma gondii","volume":"12","author":"David","year":"2016","journal-title":"PLOS Pathog."},{"key":"10.1016\/j.psychres.2020.113293_bib0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/pathogens6010003","article-title":"Is Toxoplasma gondii a trigger of bipolar disorder?","volume":"6","author":"Del Grande","year":"2017","journal-title":"Pathogens"},{"key":"10.1016\/j.psychres.2020.113293_bib0011","first-page":"509","article-title":"Seropositivity of toxoplasmosis in patients with schizophrenia","volume":"80","author":"El-Sahn","year":"2005","journal-title":"J. Egypt. Public Health Assoc."},{"key":"10.1016\/j.psychres.2020.113293_bib0012","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0304-3940(01)02242-X","article-title":"Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia","volume":"313","author":"Erhardt","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.psychres.2020.113293_bib0013","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.psychres.2016.08.056","article-title":"Toxoplasma gondii infection in schizophrenia and associated clinical features","volume":"245","author":"Esshili","year":"2016","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psychres.2020.113293_bib0014","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S1471-4922(02)02349-8","article-title":"Toxoplasma gondii MAG1 protein expression","volume":"18","author":"Ferguson","year":"2002","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.psychres.2020.113293_bib0015","series-title":"The Encyclopedia of Clinical Psychology","first-page":"1","article-title":"Structured clinical interview for the DSM (SCID)","author":"First","year":"2015"},{"key":"10.1016\/j.psychres.2020.113293_bib0016","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.17219\/acem\/61435","article-title":"Relationship between toxoplasmosis and schizophrenia: a review","volume":"26","author":"Fuglewicz","year":"2017","journal-title":"Adv. Clin. Exp. Med. Off."},{"key":"10.1016\/j.psychres.2020.113293_bib0017","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.4088\/JCP.15m10133","article-title":"Effects of cumulative Herpesviridae and Toxoplasma gondii infections on cognitive function in healthy, bipolar, and schizophrenia subjects","volume":"78","author":"Hamdani","year":"2017","journal-title":"J. Clin. Psychiatry."},{"key":"10.1016\/j.psychres.2020.113293_bib0018","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0920-9964(02)00357-2","article-title":"Drugs used in the treatment of schizophrenia and bipolar disorder inhibit the replication of Toxoplasma gondii","volume":"62","author":"Jones-Brando","year":"2003","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2020.113293_bib0019","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.12740\/PP\/25520","article-title":"New prospects for antipsychotic treatment - the role of the kynurenine pathway","volume":"48","author":"Karaku\u0142a-Juchnowicz","year":"2014","journal-title":"Psychiatr. Pol."},{"key":"10.1016\/j.psychres.2020.113293_bib0020","first-page":"61","article-title":"Viral Infections as Etiological Factors of Schizophrenia","volume":"4","author":"Kim","year":"2007","journal-title":"Psychiatry Investig."},{"key":"10.1016\/j.psychres.2020.113293_bib0021","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1001\/jamapsychiatry.2013.2437","article-title":"Increased hippocampal glutamate and volumetric deficits in unmedicated patients with schizophrenia","volume":"70","author":"Kraguljac","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.psychres.2020.113293_bib0022","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s00406-004-0481-6","article-title":"Antibodies to infectious agents in individuals with recent onset schizophrenia","volume":"254","author":"Leweke","year":"2004","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.psychres.2020.113293_bib0023","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1056\/NEJMra1808803","article-title":"Schizophrenia","volume":"381","author":"Marder","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.psychres.2020.113293_bib0024","doi-asserted-by":"crossref","unstructured":"Martynowicz, J., Augusto, L., Wek, R.C., Boehm, S.L., Sullivan, W.J., 2019. Guanabenz reverses a key behavioral change caused by latent toxoplasmosis in mice by reducing neuroinflammation. mBio doi:10.1128\/mBio.00381-19.","DOI":"10.1128\/mBio.00381-19"},{"key":"10.1016\/j.psychres.2020.113293_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0218937","article-title":"The antipsychotic medication, risperidone, causes global immunosuppression in healthy mice","volume":"14","author":"May","year":"2019","journal-title":"PLoS ONE"},{"key":"10.1016\/j.psychres.2020.113293_bib0026","article-title":"Seroprevalence of Toxoplasmosis in pregnant women in Annaba","volume":"62","author":"Messerer","year":"2014","journal-title":"Rev Epidemiol Sante Publique"},{"key":"10.1016\/j.psychres.2020.113293_bib0027","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.schres.2013.11.011","article-title":"Evaluation of kynurenine pathway metabolism in Toxoplasma gondii-infected mice: implications for schizophrenia","volume":"152","author":"Notarangelo","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2020.113293_bib0028","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/pim.12157","article-title":"Toxoplasma gondii-induced neuronal alterations","volume":"37","author":"Parlog","year":"2015","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.psychres.2020.113293_bib0029","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/schbul\/sbw221","article-title":"Kynurenic acid in schizophrenia: a systematic review and meta-analysis","volume":"43","author":"Plitman","year":"2017","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2020.113293_bib0030","doi-asserted-by":"crossref","first-page":"e23866","DOI":"10.1371\/journal.pone.0023866","article-title":"The neurotropic parasite Toxoplasma gondii increases dopamine metabolism","volume":"6","author":"Prandovszky","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.psychres.2020.113293_bib0031","doi-asserted-by":"crossref","first-page":"9976","DOI":"10.1021\/acs.jmedchem.7b01192","article-title":"Inhibition of calcium dependent protein kinase 1 (CDPK1) by pyrazolopyrimidine analogs decreases establishment and reoccurrence of central nervous system disease by Toxoplasma gondii","volume":"60","author":"Rutaganira","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.psychres.2020.113293_bib0032","first-page":"95","article-title":"[Serodiagnosis of 2,438 cases of toxoplasmosis by immunofluorescence at the Pasteur institute of Algeria. epidemiological and clinical corollaries]","volume":"52","author":"Schneider","year":"1977","journal-title":"Arch. Inst. Pasteur Algerie."},{"key":"10.1016\/j.psychres.2020.113293_bib0033","series-title":"Schizophrenia Spectrum Disorders and Their Treatments","article-title":"Toxoplasma gondii and Schizophrenia: a Relationship That Is Not Ruled Out","author":"Sorlozano-Puerto","year":"2016"},{"key":"10.1016\/j.psychres.2020.113293_bib0034","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/acps.12423","article-title":"Beyond the association. Toxoplasma gondii in schizophrenia, bipolar disorder, and addiction: systematic review and meta-analysis","volume":"132","author":"Sutterland","year":"2015","journal-title":"Acta Psychiatr. Scand"},{"key":"10.1016\/j.psychres.2020.113293_bib0035","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1517\/17460441.2013.821108","article-title":"Novel approaches to drug design for the treatment of schizophrenia","volume":"8","author":"Taly","year":"2013","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.psychres.2020.113293_bib0036","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/pathogens6020019","article-title":"Neurophysiological changes induced by chronic Toxoplasma gondii infection","volume":"6","author":"Tedford","year":"2017","journal-title":"Pathogens"},{"key":"10.1016\/j.psychres.2020.113293_bib0037","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/schbul\/sbl050","article-title":"Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis","volume":"33","author":"Torrey","year":"2007","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2020.113293_bib0038","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/schbul\/sbs043","article-title":"Toxoplasma gondii and other risk factors for schizophrenia: an update","volume":"38","author":"Torrey","year":"2012","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2020.113293_bib0039","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/pcn.12823","article-title":"Glutamate hypothesis in schizophrenia","volume":"73","author":"Uno","year":"2019","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.psychres.2020.113293_bib0040","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.schres.2017.08.006","article-title":"Increased prevalence of Toxoplasma gondii seropositivity in patients with treatment-resistant schizophrenia","volume":"193","author":"Vlatkovic","year":"2018","journal-title":"Schizophr. Res"},{"key":"10.1016\/j.psychres.2020.113293_bib0041","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004674","article-title":"Behavioral abnormalities in a mouse model of chronic toxoplasmosis are associated with MAG1 antibody levels and cyst burden","volume":"10","author":"Xiao","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.psychres.2020.113293_bib0042","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1093\/schbul\/sby082","article-title":"Toxoplasma gondii: biological parameters of the connection to schizophrenia","volume":"44","author":"Xiao","year":"2018","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2020.113293_bib0043","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.micinf.2012.10.016","article-title":"The Toxoplasma MAG1 peptides induce sex-based humoral immune response in mice and distinguish active from chronic human infection","volume":"15","author":"Xiao","year":"2013","journal-title":"Microbes Infect."},{"key":"10.1016\/j.psychres.2020.113293_bib0044","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006040","article-title":"Evidence of increased exposure to Toxoplasma gondii in individuals with recent onset psychosis but not with established schizophrenia","volume":"11","author":"Yolken","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.psychres.2020.113293_bib0045","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.3390\/molecules24203709","article-title":"Kynurenines and the endocannabinoid system in schizophrenia: common points and potential interactions","volume":"24","author":"Z\u00e1dor","year":"2019","journal-title":"Molecules"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178120312221?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178120312221?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T05:49:27Z","timestamp":1759038567000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178120312221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":45,"alternative-id":["S0165178120312221"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2020.113293","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between schizophrenia and Toxoplasma gondii infection in Algeria","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2020.113293","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113293"}}